RUNX1 and neoplasm: In addition, in both primary cells and the cell line, RAS inhibition caused retained dephosphorylation of the translation inhibitor 4EBP1,27 thereby inactivating it, increasing the anti-tumour effect of Ch-3 and explaining the reduction in RUNX1 protein levels.